Cargando…
Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
Docetaxel is a major anticancer drug that can induce hypersensitivity reactions leading to deleterious treatment interruptions. Blood hypereosinophilia could be a biological sign, potentially lethal, of delayed visceral hypersensitivity reactions. We hypothesized this biological event is probably un...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537007/ https://www.ncbi.nlm.nih.gov/pubmed/30854809 http://dx.doi.org/10.1002/cam4.2062 |